MGC Pharmaceuticals

MGC Pharmaceuticals Ltd (LSE: MXC, ASX: MXC) is a European based bio-pharma company developing and supplying affordable standardised plant based and phytocannabinoid derived medicines to patients globally. The Company’s founders are key figures in the global

medical cannabis industry and the core business strategy is to develop and supply high quality plant and phytocannabinoid derived medicines for the growing demand in the medical markets in Europe, North America and Australasia. MGC Pharma has a robust product offering backed by a clinical pipeline with a focus on neurological, autoimmune and oncological indications.